These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1483495)

  • 1. Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.
    Ljubicić N; Bilić A; Plavsić V
    Eur J Clin Pharmacol; 1992; 43(5):555-8. PubMed ID: 1483495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.
    Fujimura A; Kajiyama H; Ebihara A
    Eur J Clin Pharmacol; 1987; 31(5):605-7. PubMed ID: 3549322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.
    Fujimura A; Ebihara A
    Hypertension; 1988 May; 11(5):491-4. PubMed ID: 3284821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B; Jensen L; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers.
    Stichtenoth DO; Wagner B; Frölich JC
    J Investig Med; 1998 Aug; 46(6):290-6. PubMed ID: 9737091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.
    Rathaus M; Bernheim J
    Isr J Med Sci; 1982 Feb; 18(2):231-4. PubMed ID: 6950926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
    Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats.
    Fujimura A; Sudoh T; Ebihara A
    Life Sci; 1994; 55(9):707-11. PubMed ID: 8065233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2.
    Katayama S; Attallah AA; Stahl RA; Bloch DL; Lee JB
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F555-61. PubMed ID: 6594069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin on renal function in cirrhosis.
    Ginès A; Salmerón JM; Ginès P; Jiménez W; Saló J; Piera C; Clària J; Rivera F; Arroyo V; Rodés J
    Gastroenterology; 1992 Dec; 103(6):1868-74. PubMed ID: 1360435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
    Mansurov KhKh; Dustov AD
    Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B; Sørensen SS; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
    Stanley AJ; Bouchier IA; Hayes PC
    Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
    Scherer B; Witzgall H; Weber PC
    Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.